Top compounds associated with response to TMEM59L


Feature Type Standardized
Nominal ANOVA
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.11 0.002
mRNA paclitaxel GDSC1000 pan-cancer AAC -0.18 0.002
mRNA PX-12 CTRPv2 pan-cancer AAC 0.098 0.002
mRNA CBB-1007 CTRPv2 pan-cancer AAC 0.18 0.002
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
Download CSV